LILRB3
LILRB3,全稱為白細胞免疫球蛋白樣受體B3,也被稱為ILT5、LIR-3、CD85a等,是一類主要在小膠質細胞中表達的蛋白。LILRB3屬于抑制性白細胞免疫球蛋白樣受體(LILR)家族成員,該家族的受體在維持免疫穩態和形成針對病原體的免疫反應中發揮重要作用。LILRB3通過其胞質區中的免疫受體酪氨酸基抑制基序(ITIMs)與其他蛋白結合,從而抑制免疫細胞的活化和增殖,發揮免疫調節功能。研究表明,LILRB3的表達與多種腫瘤相關,如急性髓系白血病、結直腸癌和神經膠質瘤等,其高表達往往與腫瘤的進展和不良預后相關。針對LILRB3的藥物研發主要集中在免疫治療領域,通過阻斷LILRB3與其配體的結合,解除腫瘤細胞的免疫抑制狀態,從而增強抗腫瘤免疫反應。目前,已有多種針對LILRB3的抗體和CAR T細胞療法進入臨床研究階段,展現出良好的抗腫瘤活性。
熱銷產品
LILRB3 Antibody (CSB-PA012941LA01HU)
驗證數據

Western Blot
Positive WB detected in: HepG2 whole cell lysate
All lanes: LILRB3 antibody at 3.9µg/ml
Secondary
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 70, 72 kDa
Observed band size: 70 kDa

Immunofluorescence staining of NIH/3T3 cells with CSB-PA012941LA01HU at 1:100, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
LILRB3 Antibodies
LILRB3 for Homo sapiens (Human)
產品貨號 | 產品名稱 | 種屬反應性 | 應用類型 |
---|---|---|---|
CSB-PA888287 | LILRB3 Antibody | Human | ELISA,IHC |
CSB-PA012941LA01HU | LILRB3 Antibody | Human | ELISA, WB, IF |
CSB-PA012941LC01HU | LILRB3 Antibody, FITC conjugated | Human | |
CSB-PA012941LD01HU | LILRB3 Antibody, Biotin conjugated | Human | ELISA |
LILRB3 Proteins
LILRB3 Proteins for Homo sapiens (Human)
產品貨號 | 產品名稱 | 來源 |
---|---|---|
CSB-YP012941HU1 CSB-EP012941HU1 CSB-BP012941HU1 CSB-MP012941HU1 CSB-EP012941HU1-B |
Recombinant Human Leukocyte immunoglobulin-like receptor subfamily B member 3 (LILRB3), partial | Yeast E.coli Baculovirus Mammalian cell In Vivo Biotinylation in E.coli |
CSB-CF012941HU | Recombinant Human Leukocyte immunoglobulin-like receptor subfamily B member 3 (LILRB3) | in vitro E.coli expression system |